UBS Knock-Out ABT/ DE000UM2YQ40 /
04/06/2024 21:49:01 | Var.-0.06 | Denaro22:00:15 | Lettera22:00:15 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
1.50EUR | -3.85% | - Quantità in denaro: - |
- Quantità in lettera: - |
Abbott Laboratories | 119.0293 USD | 31/12/2078 | Put |
GlobeNewswire
22:21
The Catholic University of America Champions Sustainable Future with a Community Solar Project by St...
GlobeNewswire
22:20
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market ...
GlobeNewswire
22:15
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
22:15
CEA Industries Inc. Announces Reverse Stock Split to be Effective June 7, 2024; Publicly Traded Warr...
GlobeNewswire
22:10
ROSEN, A TOP RANKED LAW FIRM, Encourages Toyota Motor Corporation Investors to Inquire About Securit...
GlobeNewswire
22:10
Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting
GlobeNewswire
22:05
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
GlobeNewswire
22:05
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
22:05
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
GlobeNewswire
22:05
Consolidated Water Announces Settlement of Dispute with Mexico Regarding Playas de Rosarito, Baja Ca...
GlobeNewswire
22:05
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference